Stock-Based Compensation (Details) - USD ($) $ / shares in Units, $ in Thousands | 3 Months Ended | 9 Months Ended |
Sep. 30, 2019 | Sep. 30, 2018 | Sep. 30, 2019 | Sep. 30, 2018 |
Stock Options/SARs and Employee Stock Purchase Plan (ESPP) Disclosures [Line Items] | | | | | | | |
Stock-Based Compensation Expenses | | $ 54,670 | | $ 49,001 | $ 132,323 | | $ 116,290 |
Common Shares Available for Grant | | 7,700,000 | | | 7,700,000 | | |
Unrecognized compensation expense | [1] | $ 100,500 | | | $ 100,500 | | |
Weighted average period over which unrecognized compensation expense will be recognized (in years) | | | | | 2 years 2 months 12 days | | |
Stock Options and SARs | | | | | | | |
Stock Options/SARs and Employee Stock Purchase Plan (ESPP) Disclosures [Line Items] | | | | | | | |
Stock-based compensation expense related to stock options, SAR and ESPP grants | | $ 20,400 | | $ 21,700 | $ 47,800 | | $ 45,400 |
Weighted Average Fair Values And Valuation Assumptions Used To Value Stock Option/SARs, ESPP, and Performance Units/Stock Stock-Based Compensation [Abstract] | | | | | | | |
Weighted Average Fair Value of Grants (price per share) | | | | | $ 19.49 | | $ 33.49 |
Expected Volatility (in hundredths) | | | | | 32.01% | | 28.22% |
Risk-Free Interest Rate (in hundredths) | | | | | 1.69% | | 2.68% |
Dividend Yield (in hundredths) | | | | | 1.39% | | 0.72% |
Expected Life (in years) | | | | | 5 years 1 month 6 days | | 5 years |
Stock Options and SARs Rollforward [Abstract] | | | | | | | |
Outstanding at January 1 (in shares) | | | | | 8,310,000 | | 9,103,000 |
Granted (in shares) | | | | | 1,946,000 | | 1,884,000 |
Exercised (1) (in shares) | [1] | | | | (586,000) | | (2,144,000) |
Forfeited (in shares) | | | | | (200,000) | | (167,000) |
Outstanding at September 30 (2) (in shares) | [2] | 9,470,000 | | 8,676,000 | 9,470,000 | | 8,676,000 |
Stock Options and SARs Vested or Expected to Vest (3) (in shares) | [3] | 9,127,000 | | 8,316,000 | 9,127,000 | | 8,316,000 |
Stock Options and SARs Exercisable at September 30 (4) (in shares) | [4] | 5,307,000 | | 4,202,000 | 5,307,000 | | 4,202,000 |
Intrinsic Value of Stock Options/SARs Exercised | [1] | | | | $ 13,300 | | $ 103,700 |
Weighted Average Remaining Contractual Life for Stock Options/SARs Outstanding (in years) | | | | | 4 years 6 months | | 4 years 9 months 18 days |
Intrinsic Value of Stock Options/SARs Vested or Expected to Vest | [1] | $ 4,800 | | $ 261,900 | $ 4,800 | | $ 261,900 |
Weighted average remaining contractual life for stock options/SARs vested or expected to vest (in years) | | | | | 4 years 6 months | | 4 years 8 months 12 days |
Aggregate Intrinsic Value for Exercisable Units | [1] | 4,700 | | 175,500 | $ 4,700 | | $ 175,500 |
Weighted average remaining contractual life for exercisable options/SARs (in years) | | | | | 3 years 3 months 18 days | | 3 years 4 months 24 days |
Weighted Average Grant Price Stock Option and SARs [Rollforward] | | | | | | | |
Intrinsic Value of Stock Options/SARs Outstanding | [1] | $ 4,800 | | $ 269,100 | $ 4,800 | | $ 269,100 |
Outstanding at January 1 (price per share) | | | | | $ 96.90 | | $ 83.89 |
Granted (price per share) | | | | | 75.43 | | 126.65 |
Exercised (1) (price per share) | [1] | | | | 61.19 | | 69.62 |
Forfeited (price per share) | | | | | 104.89 | | 91.89 |
Outstanding at September 30 (2) (price per share) | [2] | $ 94.53 | | $ 96.55 | 94.53 | | 96.55 |
Vested or Expected to Vest (3) (price per share) | [3] | 94.51 | | 96.08 | 94.51 | | 96.08 |
Exercisable at September 30 (4) (price per share) | [4] | $ 94.08 | | $ 85.80 | 94.08 | | 85.80 |
ESPP | | | | | | | |
Weighted Average Fair Values And Valuation Assumptions Used To Value Stock Option/SARs, ESPP, and Performance Units/Stock Stock-Based Compensation [Abstract] | | | | | | | |
Weighted Average Fair Value of Grants (price per share) | | | | | $ 22.83 | | $ 25.52 |
Expected Volatility (in hundredths) | | | | | 34.83% | | 24.36% |
Risk-Free Interest Rate (in hundredths) | | | | | 2.28% | | 1.86% |
Dividend Yield (in hundredths) | | | | | 1.04% | | 0.64% |
Expected Life (in years) | | | | | 15 days | | 15 days |
Restricted Stock And Restricted Stock Units | | | | | | | |
Stock Options/SARs and Employee Stock Purchase Plan (ESPP) Disclosures [Line Items] | | | | | | | |
Unrecognized compensation expense | [1] | $ 227,500 | | | $ 227,500 | | |
Weighted average period over which unrecognized compensation expense will be recognized (in years) | | | | | 2 years | | |
Intrinsic value released during the year | [1] | | | | $ 61,200 | | $ 80,200 |
Aggregate intrinsic value of stock and units outstanding | [1] | 345,800 | | $ 489,700 | 345,800 | | 489,700 |
Restricted Stock/Restricted Stock Units [Roll Forward] | | | | | | | |
Share-Based Compensation Arrangement By Restricted Stock And Restricted Stock Units Compensation Cost | [1] | $ 24,700 | | $ 17,500 | $ 71,100 | | $ 58,800 |
Outstanding at January 1 (in shares) | | | | | 3,792,000 | | 3,905,000 |
Granted (in shares) | | | | | 1,728,000 | | 792,000 |
Released (1) (in shares) | [5] | | | | (732,000) | | (708,000) |
Forfeited (in shares) | | | | | (129,000) | | (150,000) |
Outstanding at September 30 (2) (in shares) | [6] | 4,659,000 | | 3,839,000 | 4,659,000 | | 3,839,000 |
Weighted Average Grant Price Restricted Stock and Restricted Stock Units [Roll Forward] | | | | | | | |
Outstanding at January 1 (price per share) | | | | | $ 96.64 | | $ 88.57 |
Granted (price per share) | | | | | 80.12 | | 117.67 |
Released (1) (price per share) | [5] | | | | 97.51 | | 77.46 |
Forfeited (price per share) | | | | | 97.81 | | 91.36 |
Outstanding at September 30 (2) (price per share) | [6] | $ 90.34 | | $ 96.52 | $ 90.34 | | $ 96.52 |
Performance Unit | | | | | | | |
Stock Options/SARs and Employee Stock Purchase Plan (ESPP) Disclosures [Line Items] | | | | | | | |
Stock-Based Compensation Expenses | [1] | $ 9,600 | | $ 9,800 | $ 13,400 | | $ 12,100 |
Unrecognized compensation expense | | 10,100 | | | $ 10,100 | | |
Weighted average period over which unrecognized compensation expense will be recognized (in years) | | | | | 2 years 2 months 12 days | | |
Intrinsic value released during the year | [1] | | | | $ 15,400 | | 17,700 |
Aggregate intrinsic value of stock and units outstanding | | $ 44,400 | | $ 68,000 | $ 44,400 | | $ 68,000 |
Restricted Stock/Restricted Stock Units [Roll Forward] | | | | | | | |
Outstanding at January 1 (in shares) | | | | | 539 | | 502 |
Granted (in shares) | | | | | 172 | | 107 |
Granted for Performance Multiple (1) | [7] | | | | 72 | | 72 |
Released (1) (in shares) | | | | | 185 | | 148 |
Forfeited (in shares) | | | | | 0 | | 0 |
Outstanding at September 30 (2) (in shares) | [8] | 598 | [9] | 533 | 598 | [9] | 533 |
Weighted Average Grant Price Restricted Stock and Restricted Stock Units [Roll Forward] | | | | | | | |
Outstanding at January 1 (price per share) | | | | | $ 101.53 | | $ 90.96 |
Granted (price per share) | | | | | 75.09 | | 127 |
Granted for Performance Multiple (1) (in dollars per share) | [7] | | | | 69.43 | | 101.87 |
Released (1) (price per share) | | | | | 94.63 | | 84.43 |
Forfeited (price per share) | | | | | 0 | | 0 |
Outstanding at September 30 (2) (price per share) | [8] | $ 92.19 | | $ 101.50 | $ 92.19 | | $ 101.50 |
Performance Units and Performance Stock Disclosures [Abstract] | | | | | | | |
Performance Period for Performance Units and Shares | | 3 years | | | | | |
Minimum Performance Multiple at the Completion of the Performance Period | | 0.00% | | | | | |
Maximum Performance Multiple at the Completion of the Performance Period | | 200.00% | | | 200.00% | | |
Minimum Performance Units and Stock Allowed to be Outstanding | | | | | 102,000 | | |
Maximum Performance Units and Stock Allowed to be Outstanding | | | | | 1,094,000 | | |
Lease and Well | | | | | | | |
Stock Options/SARs and Employee Stock Purchase Plan (ESPP) Disclosures [Line Items] | | | | | | | |
Stock-Based Compensation Expenses | | $ 13,300 | | $ 12,900 | $ 40,600 | | $ 37,100 |
Gathering and Processing Costs | | | | | | | |
Stock Options/SARs and Employee Stock Purchase Plan (ESPP) Disclosures [Line Items] | | | | | | | |
Stock-Based Compensation Expenses | | 300 | | 100 | 800 | | 300 |
Exploration Costs | | | | | | | |
Stock Options/SARs and Employee Stock Purchase Plan (ESPP) Disclosures [Line Items] | | | | | | | |
Stock-Based Compensation Expenses | | 5,200 | | 5,800 | 18,100 | | 18,400 |
General and Administrative | | | | | | | |
Stock Options/SARs and Employee Stock Purchase Plan (ESPP) Disclosures [Line Items] | | | | | | | |
Stock-Based Compensation Expenses | | $ 35,900 | | $ 30,200 | $ 72,800 | | $ 60,500 |
| |
[1] | The total intrinsic value of stock options/SARs exercised during the nine months ended September 30, 2019 and 2018 was $13.3 million and $103.7 million , respectively. The intrinsic value is based upon the difference between the market price of EOG's common stock on the date of exercise and the grant price of the stock options/SARs. | |
[2] | The total intrinsic value of stock options/SARs outstanding at September 30, 2019 and 2018 was $4.8 million and $269.1 million , respectively. At September 30, 2019 and 2018 , the weighted average remaining contractual life was 4.5 years and 4.8 years , respectively. | |
[3] | The total intrinsic value of stock options/SARs vested or expected to vest at September 30, 2019 and 2018 was $4.8 million and $261.9 million , respectively. At September 30, 2019 and 2018 , the weighted average remaining contractual life was 4.5 years and 4.7 years , respectively. | |
[4] | The total intrinsic value of stock options/SARs exercisable at September 30, 2019 and 2018 was $4.7 million and $175.5 million , respectively. At September 30, 2019 and 2018 , the weighted average remaining contractual life was 3.3 years and 3.4 years , respectively. | |
[5] | The total intrinsic value of restricted stock and restricted stock units released during the nine months ended September 30, 2019 and 2018 was $61.2 million and $80.2 million , respectively. The intrinsic value is based upon the closing price of EOG's common stock on the date the restricted stock and restricted stock units are released. | |
[6] | The total intrinsic value of restricted stock and restricted stock units outstanding at September 30, 2019 and 2018 was $345.8 million and $489.7 million , respectively. | |
[7] | Upon completion of the Performance Period for the performance units granted in 2015 and 2014, a performance multiple of 200% was applied to each of the grants resulting in additional grants of performance units in February 2019 and February 2018, respectively. | |
[8] | The total intrinsic value of performance units outstanding at September 30, 2019 and 2018 was approximately $44.4 million and $68.0 million , respectively. | |
[9] | The total intrinsic value of performance units released during the nine months ended September 30, 2019 and 2018 , was $15.4 million and $17.7 million , respectively. The intrinsic value is based upon the closing price of EOG's common stock on the date the performance units are released. | |